Skip to main content
AIDiveForge AIDiveForge

Genomi vs Myco Brain

Genomi and Myco Brain are both agent frameworks tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

Genomi

Genomi

The core workflow is four steps: install the agent harness, point it at your raw genome file on disk, build a local SQLite index, then ask questions through whichever AI agent you already run — Claude Code, Cursor, Gemini CLI, Goose, and others are listed as compatible. Pharmacogenomics, carrier status, polygenic risk scores, nutrigenomics, and ancestry PCA projection are all covered through distinct skill modules backed by ClinVar, PharmCAT, PGS Catalog, HPO, GenCC, and 1000 Genomes reference data. The privacy architecture is explicit: raw genome data stays on disk, and only the specific evidence snippets relevant to a query cross the boundary to whatever LLM handles the response. The vendor marks this as experimental and not for clinical use — which means researchers and privacy-conscious individuals exploring personal data are the intended audience, not clinical teams expecting diagnostic-grade output.

Myco Brain

Myco Brain

The core mechanic is deterministic writes: the application code writes facts to Myco's Postgres store, not the LLM, so every stored fact carries a source document, a confidence score, and a full audit trail queryable via brain_why. One MCP server exposes that memory to Claude Code, Cursor, Codex, Windsurf, and any other MCP-compatible client simultaneously — write from Claude Desktop, retrieve from Cursor, no sync step required. The vendor publishes a 500-question LongMemEval result and a recall@5 figure using a recency reranker, both on the full benchmark set. The hard ceiling appears when your agents need to act on what they remember — Myco stores and retrieves facts; it does not plan, route, or execute tasks, so orchestration logic lives elsewhere.

AttributeGenomiMyco Brain
PricingFreeFree
Free trialNoNo
Open sourceYesYes
Has APINoNo
Self-hosted optionYesYes
PlatformsLinux, macOS, Windows (Python-based)Postgres, Docker, MCP clients
Released20242026
Pros
  • Local-first data architecture keeps the raw genome file on disk and only sends queried evidence snippets to the LLM, so teams with strict data policies can explore personal genomic data without uploading a single variant to a third-party server.
  • Skill modules cover pharmacogenomics via PharmCAT and ClinPGx, carrier status via ClinVar and HPO, polygenic risk via PGS Catalog, and ancestry via 1000 Genomes PCA — so a researcher doesn't have to stitch together five separate tools and manually reconcile their outputs.
  • Each answer carries source attribution and stated evidence limits, which means you can trace a finding back to ClinVar or GenCC rather than accepting a response with no provenance — a real gap in generic LLM genomic Q&A.
  • Agent-agnostic MCP and skills-host architecture plugs into whichever AI agent a team already runs, so there is no forced migration to a new interface or locked-in model provider.
  • Apache-2.0 open-source license with self-hosted deployment means developers building agent-based genomic analysis tools can inspect, modify, and extend the skill layer without negotiating commercial terms.
  • Deterministic write path means the LLM never authors the facts stored in memory, so every retrieved fact links to a source document and confidence score — which means regulated teams get an audit trail without building one themselves.
  • One MCP server shared across all connected clients, so a fact written from Claude Desktop is immediately readable by a Cursor agent without a sync job or intermediate API call.
  • Full-stack boot with docker compose and no required API keys, so teams evaluate and prototype without committing credentials or cloud spend before the architecture is validated.
  • Content-hash deduplication on document ingestion, so re-importing the same ChatGPT or Claude export twice does not corrupt or inflate the memory store.
  • Graph queries over entity relationships via the built-in tools, so agents can retrieve not just isolated facts but the web of connections between people, decisions, and documents in the store.
Cons
  • Installation requires following a source-code setup guide and configuring an AI agent to connect to the harness — non-technical users hit a wall before they ask a single question, and there is no hosted web interface to fall back on.
  • The project is vendor-labeled experimental, which means skill coverage, reference database freshness, and edge-case handling are not production-guaranteed; teams relying on consistent outputs for any regulated or clinical-adjacent workflow will find the absence of validation documentation disqualifying and will move to a certified clinical genomics platform instead.
  • There is no hosted API, so teams building products that need to serve genomic queries to end users must provision and maintain their own infrastructure — at scale, that maintenance burden is not accounted for in the zero-cost licensing.
  • Evidence snippets sent to an external LLM during a query still cross a data boundary, even if the raw genome file stays local; teams operating under strict genomic data agreements need to verify that snippet-level transmission satisfies their compliance posture before deploying, and the tool provides no compliance documentation to support that review.
  • Myco stores and retrieves facts — it has no planner, no task router, and no execution loop. Teams building agents that need to act on retrieved memory must implement that logic themselves, which means maintaining a separate orchestration layer alongside the memory layer.
  • The self-hosted path requires running Postgres 16 with pgvector and managing that infrastructure. Teams without existing Postgres ops experience hit configuration and maintenance overhead that the single docker compose up does not eliminate long-term.
  • Semantic search requires a local Ollama instance or an external embedding provider; teams without GPU-capable self-host infrastructure who want semantic recall beyond full-text search are blocked until the cloud offering exits beta — at which point they are evaluating a hosted product with a waitlist rather than a drop-in replacement.
  • No API surface is exposed outside the MCP protocol, so teams whose agents run outside MCP-compatible clients cannot integrate without building a custom MCP wrapper — teams with that constraint typically move to a vector database with a standard REST or gRPC API instead.
Bottom line

Genomi and Myco Brain are closely matched on pricing model, openness, and API availability — pick by feature set and platform support in the table above.

Frequently asked questions

What is the difference between Genomi and Myco Brain?

Genomi is Free and open source, while Myco Brain is Free and open source. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is Genomi better than Myco Brain?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.

Genomi vs Myco Brain: which should I pick?

Pick Genomi if its pricing model, openness, or platform fit matches your constraints; pick Myco Brain otherwise. Check free-trial availability on each listing if you want to test before committing.

Comparison data is sourced and verified by the AIDiveForge data pipeline. AIDiveForge is editorially independent.